However, to the best of our knowledge, no randomized feeding trial so far has formally tested the effects of isocaloric protein restriction (PR) on circulating levels of IGF-1 and IGF binding proteins in men with localized prostate cancer who might benefit the most from a sustained reduction in IGF-1 levels
This extensive distribution framework enhances the companys global market presence and accessibility
[GLP-1 meds] are a game changer, says Michael Treskow, partner at Eight Roads Ventures, adding it would be strange if a startup working in the weight loss space wasnt looking into how they could add the drugs into their offering
JAMA Netw Open 7(8):e2427258e2427258 Miller MG, Terebuh P, Kaelber DC, Xu R, Davis PB (2024) Characterizing GLP-1 receptor agonist use in preadolescent and adolescent populations
Cellular Molecular Medicine 25 (5), 26452654